APA (7th ed.) Citation

(2020). Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.

Chicago Style (17th ed.) Citation

Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies with Renin Angiotensin System Blockers. 2020.

MLA (8th ed.) Citation

Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies with Renin Angiotensin System Blockers. 2020.

Warning: These citations may not always be 100% accurate.